Guoqing Zhang et al. described a patient with NSCLC with EGFR fusion and EGFR amplification who achieved a significant antitumor response from treatment with gefitinib combined with cetuximab [37]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.